Canada Develops RWE Guide Anticipating Increased Submissions

New Canadian guidance is expected to help drug sponsors collect high-quality, real-world data that meets international evidence requirements for approval. It focuses on good practices for protocol development and data collection.

ICON_Featured_Image_1200x675.jpg
Health Canada Wants To Optimize The Use Of Real-World Evidence • Source: Shutterstock

More from Canada

More from North America